newsfilter
← Latest News
GlobeNewswire·

SCYNEXIS to Feature SCY-247 in a Pipeline Presentation at IDWeek

JERSEY CITY, N.J., Oct. 21, 2026 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ:SCYX) ("SCYNEXIS" or the "Company"), a clinical-stage biotechnology company dedicated to advancing innovative solutions for